Literature DB >> 9541497

Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

P Cullen1, A Cignarella, B Brennhausen, S Mohr, G Assmann, A von Eckardstein.   

Abstract

In this study, we investigated the impact of the common apoE polymorphism on apoE metabolism and cholesterol homeostasis in monocyte-derived macrophages isolated from E2/2, E3/3, and E4/4 subjects. Unloaded cells of all genotypes contained similar amounts of free cholesterol, cholesteryl ester, and apoE mRNA. E3/3 cells secreted 77 and 30% more apoE than E2/2 or E4/4 cells, respectively. Pulse-chase studies confirmed that the apoE secretion rate was greatest in E3/3 and least in E2/2 cells and showed that a portion of apoE2, but not apoE3 or apoE4, was degraded intracellularly. Surface binding of apoE was greatest in E4/4 cells, as revealed by heparinase treatment. On cholesterol loading with acetylated LDL, apoE mRNA levels and protein secretion rose most in E4/4 and least in E2/2 cells. Cholesterol and cholesteryl ester content, however, rose most in E2/2 and least in E3/3 cells. Incubations with 3H-cholesterol-labeled acetylated LDL revealed that E2/2 cells were most efficient at secreting cholesterol. The greatest reuptake of 3H-cholesterol-rich particles was from E4/4 macrophage- conditioned media. Thus, E2/2 macrophages, despite a low apoE secretion rate, are protected from cholesterol storage by apoE-mediated cholesterol efflux. In E3/3 macrophages, cholesterol accumulation is lessened by a high basal apoE secretion rate. E4/4 macrophages secrete the most apoE but lack effective net cholesterol efflux due to enhanced surface binding and reuptake of cholesterol-rich particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541497      PMCID: PMC508748          DOI: 10.1172/JCI119887

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages.

Authors:  G Schmitz; H Fischer; M Beuck; K P Hoecker; H Robenek
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

2.  Post-translational regulation of macrophage apoprotein E production.

Authors:  T Mazzone; L Pustelnikas; C A Reardon
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

3.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.

Authors:  R E Pitas; J K Boyles; S H Lee; D Foss; R W Mahley
Journal:  Biochim Biophys Acta       Date:  1987-01-13

4.  Macrophage free cholesterol content regulates apolipoprotein E synthesis.

Authors:  T Mazzone; H Gump; P Diller; G S Getz
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

5.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.

Authors:  E Boerwinkle; S Visvikis; D Welsh; J Steinmetz; S M Hanash; C F Sing
Journal:  Am J Med Genet       Date:  1987-07

Review 7.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  A rapid micromethod for apolipoprotein E phenotyping directly in serum.

Authors:  L M Havekes; P de Knijff; U Beisiegel; J Havinga; M Smit; E Klasen
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

10.  Regulation of macrophage apolipoprotein E gene expression by cholesterol.

Authors:  T Mazzone; K Basheeruddin; C Poulos
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

View more
  26 in total

1.  The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.

Authors:  Michael P Corcoran; Alice H Lichtenstein; Mohsen Meydani; Alice Dillard; Ernst J Schaefer; Stefania Lamon-Fava
Journal:  J Mol Endocrinol       Date:  2011-08       Impact factor: 5.098

2.  Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Authors:  Taro E Akiyama; Shuichi Sakai; Gilles Lambert; Christopher J Nicol; Kimihiko Matsusue; Satish Pimprale; Ying-Hue Lee; Mercedes Ricote; Christopher K Glass; H Bryan Brewer; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Authors:  Delphine Eberlé; Roy Y Kim; Fu Sang Luk; Nabora Soledad Reyes de Mochel; Nathalie Gaudreault; Victor R Olivas; Nikit Kumar; Jessica M Posada; Andrew C Birkeland; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-22       Impact factor: 8.311

4.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Authors:  C Knouff; M E Hinsdale; H Mezdour; M K Altenburg; M Watanabe; S H Quarfordt; P M Sullivan; N Maeda
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  Expression of the human apoE2 isoform in adipocytes: altered cellular processing and impaired adipocyte lipogenesis.

Authors:  Zhi H Huang; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2011-07-08       Impact factor: 5.922

6.  Effects of SNPs at newly identified lipids loci on blood lipid levels and risk of coronary heart disease in Chinese Han population: a case control study.

Authors:  Ke Zhuang; Wencai Zhang; Xiaobo Zhang; Fangqin Wu; Longxian Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

7.  Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

Authors:  Valentin Blanchard; Stéphane Ramin-Mangata; Stéphanie Billon-Crossouard; Audrey Aguesse; Manon Durand; Kevin Chemello; Brice Nativel; Laurent Flet; Maud Chétiveaux; David Jacobi; Jean-Marie Bard; Khadija Ouguerram; Gilles Lambert; Michel Krempf; Mikaël Croyal
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

8.  Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations.

Authors:  Maen D Abou Ziki; Yael Strulovici-Barel; Neil R Hackett; Juan L Rodriguez-Flores; Jason G Mezey; Jacqueline Salit; Sharon Radisch; Charleen Hollmann; Lotfi Chouchane; Joel Malek; Mahmoud A Zirie; Amin Jayyuosi; Antonio M Gotto; Ronald G Crystal
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

Review 9.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

10.  Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation.

Authors:  Lance A Johnson; Hyung-Suk Kim; Melissa J Knudson; C Taylor Nipp; Xianwen Yi; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2012-11-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.